ESC 2007: Glycoprotein IIIa gene allele may lead to better choice of stent
This article was originally published in Clinica
Testing for a polymorphism of the gene for glycoprotein IIIa (GPIIIa) in patients scheduled for percutaneous coronary intervention (PCI) could help physicians decide whether to use a bare metal stent (BMS) rather than a drug-eluting stent (DES).
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.